Maxcell Communication India Private Limited has officially reported the transfer of 12,00,000 equity shares in Vivo Bio Tech Limited. This disclosure, made under SEBI’s Substantial Acquisition of Shares and Takeovers Regulations, 2011, signifies a change in the shareholding pattern of Vivo Bio Tech. The transaction, executed on August 21, 2026, involved shares held by M/s. Maxcell Communication India Private Limited, with the total holding remaining at 5.41% post-transaction.
Equity Share Transfer Disclosure
Maxcell Communication India Private Limited has formally disclosed a transaction involving the transfer of a significant block of shares in Vivo Bio Tech Limited. The company reported the disposal of 12,00,000 equity shares, representing 5.41% of the total voting capital, in Vivo Bio Tech Limited. This disclosure aligns with the requirements of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Transaction Details
The transfer of shares occurred on August 21, 2026. Following this transaction, Maxcell Communication India Private Limited’s holding in Vivo Bio Tech Limited stands at 12,00,000 equity shares, which continues to be 5.41% of the total share capital. The transaction was executed as an off-market sale.
Shareholding Context
Prior to the sale, Maxcell Communication India Private Limited held 12,00,000 equity shares, accounting for 5.41% of the total voting capital. The company is classified as a Promoter group entity for Vivo Bio Tech Limited. The total diluted share capital of Vivo Bio Tech post-acquisition/sale is estimated at 2,93,23,111 equity shares, assuming the conversion of pending warrants and exercise of ESOPs.
Source: BSE
